Stock-Based Compensation (Tables)
|
9 Months Ended |
Sep. 30, 2022 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Stock-based Compensation Expense |
The stock-based compensation expense attributable to continuing operations was included in the unaudited condensed consolidated statements of operations and comprehensive loss as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
|
(in thousands) |
| Imagery & software analytical service costs, excluding depreciation and amortization |
|
$ |
259 |
|
|
$ |
2,898 |
|
|
$ |
1,364 |
|
|
$ |
2,949 |
|
| Engineering & systems integration costs, excluding depreciation and amortization |
|
37 |
|
|
— |
|
|
202 |
|
|
— |
|
| Selling, general and administrative |
|
2,867 |
|
|
25,595 |
|
|
14,823 |
|
|
26,316 |
|
| Total stock-based compensation expense |
|
$ |
3,163 |
|
|
$ |
28,493 |
|
|
$ |
16,389 |
|
|
$ |
29,265 |
|
|
| Schedule of Share-based Payment Arrangements, Stock Options, Valuation Assumptions |
A summary of the weighted-average assumptions used by the Company is presented below for the nine months ended September 30, 2022; there were no stock options awarded during the nine months ended September 30, 2021:
|
|
|
|
|
|
| Fair value per common share |
$2.10 - $2.15 |
| Weighted-average risk-free interest rate |
3.20% - 3.38% |
| Volatility |
33.90% - 34.20% |
| Expected term (in years) |
8.0 |
| Dividend rate |
0 |
% |
|
| Share-based Payment Arrangement, Option, Activity |
A summary of the Company’s stock option activity under the Plans during the nine months ended September 30, 2022 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options |
|
Weighted-Average Exercise Price |
|
Weighted Average Contractual Term |
|
Aggregate Intrinsic Value |
|
(in thousands) |
|
|
|
(in years) |
|
(in thousands) |
| Outstanding - January 1, 2022 |
5,022 |
|
|
$ |
4.4914 |
|
|
|
|
|
| Granted |
4,654 |
|
|
2.1468 |
|
|
|
|
|
| Exercised |
(638) |
|
|
0.0565 |
|
|
|
|
|
| Forfeited |
(955) |
|
|
7.3285 |
|
|
|
|
|
| Outstanding - September 30, 2022 |
8,083 |
|
|
3.1558 |
|
|
9.11 |
|
$ |
1,924 |
|
| Exercisable - September 30, 2022 |
1,275 |
|
|
1.6698 |
|
|
6.79 |
|
1,221 |
|
| Nonvested Restricted Stock Shares Activity |
A summary of the Company’s nonvested RSA activity during the nine months ended September 30, 2022 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Awards |
|
Weighted-Average Grant-Date Fair Value |
|
(in thousands) |
|
|
| Nonvested - January 1, 2022 |
335 |
|
|
$ |
0.0121 |
|
| Vested |
(178) |
|
|
0.0121 |
|
| Canceled |
(78) |
|
|
0.0121 |
|
| Nonvested - September 30, 2022 |
79 |
|
|
0.0121 |
|
|
| Share-based Payment Arrangement, Restricted Stock Unit, Activity |
A summary of the Company’s nonvested RSU activity during the nine months ended September 30, 2022 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units |
|
Weighted-Average Grant-Date Fair Value |
|
(in thousands) |
|
|
| Nonvested - January 1, 2022 |
10,959 |
|
|
$ |
6.7675 |
|
| Granted |
4,181 |
|
|
2.0595 |
|
| Vested |
(5,968) |
|
|
6.9790 |
|
| Canceled |
(904) |
|
|
5.2863 |
|
| Nonvested - September 30, 2022 |
8,268 |
|
|
4.3961 |
|
|